** Shares of MedAdvisor MDR.AX rise 30% to A$0.13, hitting their highest levels since March 5
** The pharmaceutical co says it received a non-binding letter of intent (LOI) from a listed multinational software business with operations in Australia
** The LOI outlines a proposal to acquire the company's ANZ business division for cash - co
** It did not reveal any other details of the LOI
** Stock is biggest percentage gainer in the ASX All Ordinaries Index .AORD
** Over 1 million shares change hands, vs the 30-day average of almost 700,000
** Stock rose as much as 65% earlier in the day, marking its biggest intraday gain since March 10, 2020
** MDR stock down 55.6%, YTD
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。